ACET Q4 2022 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$76M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$32M

Net Income

-$30M

EPS (Diluted)

$-10.72

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$25M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$331M

Total Liabilities

$38M

Stockholders' Equity

$292M

Cash & Equivalents

$258M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$5M	-100.0%
Gross Profit	$0	$5M	-100.0%
Operating Income	-$32M	-$16M	-103.1%
Net Income	-$30M	-$16M	-88.9%